The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve ...

The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was ...

The new settlement reopens a path to ending Purdue’s chapter 11 case, the longest and costliest corporate bankruptcy stemming from the U.S. opioid epidemic.

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...

The Office of the Attorney General came to a $7.4 billion settlement with the Sackler family and their company, Purdue Pharma ...

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

The settlement is the largest deal to date with the people primarily who played an “instrumental role” in driving the opioid ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement with Texas and 14 other states to ...

Purdue Pharma’s Sackler family owners are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits while accepting some exposure to future litigation ...

The deal replaces a previous, $6 billion agreement that was rejected last July by the Supreme Court because it would have ...